# HORMAD1

## Overview
HORMAD1 is a gene that encodes the protein HORMA domain containing 1, which is integral to meiotic processes in germ cells. The protein is characterized by the presence of a HORMA domain, a conserved module that facilitates protein-protein interactions essential for chromosome pairing, recombination, and segregation during meiosis (Shin2010Hormad1; Fukuda2010A). HORMAD1 is a component of the synaptonemal complex and plays a pivotal role in meiotic sex chromosome inactivation and transcriptional silencing, particularly during the pachytene stage (Prince2022Functions; Shin2010Hormad1). The gene's expression is tightly regulated, and its aberrant expression is associated with various cancers, where it contributes to genomic instability and affects treatment responses (Watkins2015Genomic; Liu2022The).

## Structure
HORMAD1 is a protein characterized by the presence of a HORMA domain, which is a conserved protein-protein interaction module involved in meiotic processes. The primary structure of HORMAD1 includes a sequence of amino acids forming the HORMA domain, which is crucial for its function (Fukuda2010A). HORMAD1 exists in two isoforms: HORMAD1L, which is 392 amino acids long, and HORMAD1S, which is 374 amino acids long. Both isoforms share a 367 amino acid sequence starting at the N-terminus but have distinct C-terminal sequences. HORMAD1L contains a putative nuclear localization signal (NLS) at the C-terminal region, which is absent in HORMAD1S (Fukuda2010A).

The secondary structure of HORMAD1 involves the β5-αC loop, which plays a key role in determining the protein's conformation and function. This loop can adopt a 'loop engaged' conformation, interacting with the HORMA core, which is essential for the protein's function (Barroso2024Two). The β5-αC loop's flexibility allows for conformational plasticity, enabling HORMAD1 to respond to changes in the chromosomal environment (Barroso2024Two).

HORMAD1 undergoes post-translational modifications, such as phosphorylation, which influence its activity and interactions (Fukuda2010A). These modifications may regulate the position of the β5-αC loop and the recruitment of interactors (Barroso2024Two).

## Function
HORMAD1 is a critical component of the synaptonemal complex, which is essential for meiosis in germ cells. It plays a significant role in homologous chromosome pairing, recombination, and segregation during meiosis. The protein contains a HORMA domain and is involved in the formation of the synaptonemal complex, facilitating proper chromosome disjunction and crossover formation (Shin2010Hormad1). HORMAD1 is primarily active in the nucleus of germ cells, where it co-localizes with proteins such as SYCP2 and SYCP3 on unsynapsed chromosome axes (Shin2010Hormad1).

In healthy cells, HORMAD1 is involved in meiotic sex chromosome inactivation and transcriptional silencing, particularly during the pachytene stage of meiosis. It co-localizes with cH2AX to the sex body, playing a role in the transcriptional repression of sex chromosomes (Shin2010Hormad1). The protein is also involved in the recruitment of ATR kinase to unsynapsed regions on sex chromosomes, which is necessary for transcriptional silencing and progression beyond the pachytene stage (Prince2022Functions). HORMAD1's function is crucial for maintaining genomic integrity and ensuring the proper progression of meiosis (Shin2010Hormad1).

## Clinical Significance
HORMAD1 is implicated in various cancers due to its role in genomic stability and DNA repair. In lung cancer, HORMAD1 is significantly upregulated and associated with poor prognosis. It promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition (EMT) and activating the Wnt/β-catenin signaling pathway, which enhances the expression of EMT markers and decreases E-cadherin expression (Liu2022The). 

In triple-negative breast cancer (TNBC), HORMAD1 overexpression contributes to homologous recombination deficiency, leading to genomic instability. This deficiency is linked to increased sensitivity to platinum-based chemotherapies and PARP inhibitors, suggesting HORMAD1 as a potential biomarker for treatment response in TNBC (Watkins2015Genomic).

HORMAD1 also affects DNA mismatch repair in cancer cells by disrupting the nuclear localization of the MCM8-MCM9 complex, leading to increased mutation load and genomic instability (Liu2020Aberrantly). In ovarian cancer, silencing HORMAD1 reduces tumor growth and enhances sensitivity to chemotherapy, indicating its potential as a therapeutic target (Shahzad2013Biological).

## Interactions
HORMAD1 is involved in several interactions crucial for meiotic processes. It co-localizes with synaptonemal complex proteins SYCP2 and SYCP3 on the chromatin, forming part of the axial core essential for chromosome synapsis during meiosis (Shin2010Hormad1). HORMAD1 interacts with known axial proteins such as REC8 and SMC1b, although the biological significance of these interactions is not fully understood (Shin2010Hormad1).

HORMAD1 is also involved in the recruitment of proteins like BRCA1, ATR, and cH2AX to the sex body during meiotic sex chromosome inactivation (MSCI), indicating its role in transcriptional silencing of sex chromosomes (Shin2010Hormad1). The protein's deficiency disrupts the localization of these proteins, leading to transcriptional de-repression on the X chromosome (Shin2010Hormad1).

HORMAD1's interactions are part of a complex network necessary for proper meiotic progression, and it is suggested to modulate the action and recruitment of recombinases such as DMC1 and RAD51, which are critical for early recombination events (Shin2010Hormad1). These interactions highlight HORMAD1's essential role in maintaining genomic integrity during meiosis.


## References


[1. (Liu2020Aberrantly) Kang Liu, Yifan Wang, Quanfeng Zhu, Peng Li, Jiyuan Chen, Zhenghui Tang, Yuanming Shen, Xiaodong Cheng, Lin-Yu Lu, and Yidan Liu. Aberrantly expressed hormad1 disrupts nuclear localization of mcm8–mcm9 complex and compromises dna mismatch repair in cancer cells. Cell Death &amp; Disease, July 2020. URL: http://dx.doi.org/10.1038/s41419-020-2736-1, doi:10.1038/s41419-020-2736-1. This article has 24 citations.](https://doi.org/10.1038/s41419-020-2736-1)

[2. (Shin2010Hormad1) Yong-Hyun Shin, Youngsok Choi, Serpil Uckac Erdin, Svetlana A. Yatsenko, Malgorzata Kloc, Fang Yang, P. Jeremy Wang, Marvin L. Meistrich, and Aleksandar Rajkovic. Hormad1 mutation disrupts synaptonemal complex formation, recombination, and chromosome segregation in mammalian meiosis. PLoS Genetics, 6(11):e1001190, November 2010. URL: http://dx.doi.org/10.1371/journal.pgen.1001190, doi:10.1371/journal.pgen.1001190. This article has 183 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1001190)

[3. (Watkins2015Genomic) Johnathan Watkins, Daniel Weekes, Vandna Shah, Patrycja Gazinska, Shalaka Joshi, Bhavna Sidhu, Cheryl Gillett, Sarah Pinder, Fabio Vanoli, Maria Jasin, Markus Mayrhofer, Anders Isaksson, Maggie C.U. Cheang, Hasan Mirza, Jessica Frankum, Christopher J. Lord, Alan Ashworth, Shaveta Vinayak, James M. Ford, Melinda L. Telli, Anita Grigoriadis, and Andrew N.J. Tutt. Genomic complexity profiling reveals that hormad1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers. Cancer Discovery, 5(5):488–505, May 2015. URL: http://dx.doi.org/10.1158/2159-8290.CD-14-1092, doi:10.1158/2159-8290.cd-14-1092. This article has 123 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/2159-8290.CD-14-1092)

[4. (Prince2022Functions) Josh P. Prince and Enrique Martinez-Perez. Functions and regulation of meiotic horma-domain proteins. Genes, 13(5):777, April 2022. URL: http://dx.doi.org/10.3390/genes13050777, doi:10.3390/genes13050777. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13050777)

[5. (Liu2022The) Kang Liu, Li Cheng, Kun Zhu, Jinhu Wang, and Qiang Shu. The cancer/testis antigen hormad1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the wnt/β-catenin signaling pathway in lung cancer. Cell Death Discovery, March 2022. URL: http://dx.doi.org/10.1038/s41420-022-00946-1, doi:10.1038/s41420-022-00946-1. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-022-00946-1)

[6. (Fukuda2010A) Tomoyuki Fukuda, Katrin Daniel, Lukasz Wojtasz, Attila Toth, and Christer Höög. A novel mammalian horma domain-containing protein, hormad1, preferentially associates with unsynapsed meiotic chromosomes. Experimental Cell Research, 316(2):158–171, January 2010. URL: http://dx.doi.org/10.1016/j.yexcr.2009.08.007, doi:10.1016/j.yexcr.2009.08.007. This article has 120 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2009.08.007)

7. (Barroso2024Two) Two structurally mobile regions control the conformation and function of metamorphic meiotic HORMAD proteins. This article has 0 citations.

[8. (Shahzad2013Biological) Mian M.K. Shahzad, Yong-Hyun Shin, Koji Matsuo, Chunhua Lu, Masato Nishimura, De-Yo Shen, Yu Kang, Wei Hu, Edna M. Mora, Cristian Rodriguez-Aguayo, Arvinder Kapur, Justin Bottsford-Miller, Gabriel Lopez-Berestein, Aleksandar Rajkovic, and Anil K. Sood. Biological significance of horma domain containing protein 1 (hormad1) in epithelial ovarian carcinoma. Cancer Letters, 330(2):123–129, April 2013. URL: http://dx.doi.org/10.1016/j.canlet.2012.07.001, doi:10.1016/j.canlet.2012.07.001. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2012.07.001)